CARFILZOMIB for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 143 adverse event reports in the FDA FAERS database where CARFILZOMIB was used for Off label use.
Most Reported Side Effects for CARFILZOMIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 2,238 | 10.3% | 748 | 426 |
| Off label use | 2,120 | 9.7% | 361 | 393 |
| Death | 1,442 | 6.6% | 1,441 | 249 |
| Thrombocytopenia | 1,265 | 5.8% | 284 | 385 |
| Fatigue | 1,048 | 4.8% | 131 | 205 |
| Pneumonia | 1,016 | 4.7% | 334 | 634 |
| Pyrexia | 969 | 4.4% | 170 | 590 |
| Anaemia | 910 | 4.2% | 212 | 373 |
| Dyspnoea | 881 | 4.0% | 141 | 338 |
| Neutropenia | 874 | 4.0% | 190 | 213 |
| Diarrhoea | 764 | 3.5% | 157 | 285 |
| Acute kidney injury | 746 | 3.4% | 201 | 493 |
| Nausea | 707 | 3.2% | 113 | 194 |
| Disease progression | 622 | 2.9% | 166 | 144 |
| Hypertension | 609 | 2.8% | 127 | 228 |
Other Indications for CARFILZOMIB
Plasma cell myeloma (15,333)
Product used for unknown indication (4,210)
Plasma cell myeloma refractory (1,208)
Plasma cell leukaemia (186)
Acute lymphocytic leukaemia (86)
Plasma cell myeloma recurrent (66)
Plasmacytoma (66)
Chemotherapy (51)
Amyloidosis (44)
Small cell lung cancer (40)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)